US Bancorp
AUTL

US Bancorp’s Autolus Therapeutics AUTL Stock Holding History

US Bancorp’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-64
Closed -$99 – 4160
2025
Q1 		$99 Sell
64
-2,038
-97% -$4.14K ﹤0.01% 4139
2024
Q4 		$4.94K Buy
2,102
+1,438
+217% +$4.86K ﹤0.01% 3648
2024
Q3 		$2.41K Sell
664
-718
-52% -$2.86K ﹤0.01% 3738
2024
Q2 		$4.81K Sell
1,382
-2
-0.1% -$9 ﹤0.01% 3528
2024
Q1 		$8.83K Hold
1,384
– – ﹤0.01% 3368
2023
Q4 		$8.91K Buy
+1,384
New +$5.28K ﹤0.01% 3339
2022
Q4 		– Sell
-7,652
Closed -$16K – 4141
2022
Q3 		$16K Buy
+7,652
New +$22.7K ﹤0.01% 3134
2022
Q2 		– Sell
-301
Closed -$1K – 4073
2022
Q1 		$1K Sell
301
-6,872
-96% -$28.9K ﹤0.01% 3910
2021
Q4 		$37K Buy
7,173
+2,721
+61% +$16.3K ﹤0.01% 2802
2021
Q3 		$30K Buy
4,452
+2,875
+182% +$18.2K ﹤0.01% 2905
2021
Q2 		$11K Buy
1,577
+908
+136% +$5.64K ﹤0.01% 3359
2021
Q1 		$4K Buy
669
+130
+24% +$962 ﹤0.01% 3534
2020
Q4 		$5K Sell
539
-431
-44% -$4.59K ﹤0.01% 3385
2020
Q3 		$11K Buy
970
+505
+109% +$7.32K ﹤0.01% 3038
2020
Q2 		$8K Sell
465
-1,105
-70% -$12.3K ﹤0.01% 3152
2020
Q1 		$10K Buy
1,570
+1,328
+549% +$12.3K ﹤0.01% 3016
2019
Q4 		$3K Buy
+242
New +$3.17K ﹤0.01% 3383

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

US Bancorp's AUTL Position: Q2 2025 in Review

US Bancorp sold out of Autolus Therapeutics (AUTL) in Q2 2025, closing a stake of 64 shares — an estimated $99 sold.

US Bancorp first reported a position in AUTL in Q4 2019 and held it in 17 quarters. The position peaked at $37K in Q4 2021. 94 funds tracked by Wall St. Rank hold AUTL as of Q2 2025.

  • US Bancorp reported no remaining Autolus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • US Bancorp sold 64 Autolus Therapeutics shares in Q2 2025, an estimated $99.
  • US Bancorp first reported a position in Autolus Therapeutics in Q4 2019 and held it in 17 quarters.
  • US Bancorp's Autolus Therapeutics position peaked at $37K in Q4 2021.
  • 94 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2025.

Based on US Bancorp's 13F filing for Q2 2025, filed 24 Jul 2025.